← Leaderboards
Erica Reeves
Reveragen Biopharma, Inc.
$375,244
Attributed
$375,244
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$375,244 · 1
By mechanism
R41$375,244 · 1
Top collaborators
No co-investigators on record.
Most similar at Reveragen Biopharma, Inc.
Same institution · by research overlap
- Eric P Hoffman$47,884,792
- Paula R Clemens$13,640,837
- Jesse Damsker$1,130,321
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAfrican AmericanAirway EpitheliumAirway InflammationAnti-InflammatoryAnti-Inflammatory AgentsAsthmaBaseBreathingBronchial EpitheliumCell Culture TechniquesCell CycleCell Cycle InhibitionCell LineCellsCell SurvivalCharacteristicsChildChronicClinical TrialsCollaborationsCompetitive BindingComplexAdverse Effects